MedTrace Logo

Predisposing Factors Associated With Chemotherapy Toxicity in Elderly Cancer Patients

NCT02317757 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2016-04-04

No results posted yet for this study

Summary

These days, there is higher proportion of elderly cancer patients. Most of them have comorbidities, borderline performance status and nutritional status. The discontinuation of chemotherapy due to unbearable toxicities was not uncommon. Comprehensive geriatric assessment might be beneficial in selection of suitable elderly patients for chemotherapy administration.

Conditions

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Suthinee Ithimakin, MD · Mahidol University

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-06-30
Completion
2016-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02317757 on ClinicalTrials.gov